CA2235942A1 - Tricyclic erythromycin derivatives - Google Patents
Tricyclic erythromycin derivativesInfo
- Publication number
- CA2235942A1 CA2235942A1 CA 2235942 CA2235942A CA2235942A1 CA 2235942 A1 CA2235942 A1 CA 2235942A1 CA 2235942 CA2235942 CA 2235942 CA 2235942 A CA2235942 A CA 2235942A CA 2235942 A1 CA2235942 A1 CA 2235942A1
- Authority
- CA
- Canada
- Prior art keywords
- compounds
- erythromycin derivatives
- tricyclic
- tricyclic erythromycin
- antibacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Compounds, or pharmaceutically acceptable salts and esters thereof, of formulae (I); (II); (III) or (IV) wherein A, B, D and E, R1, R2 and Z are specifically defined, having antibacterial activity, pharmaceutical compositions containing said compounds, treatment of antibacterial infections with such compositions, and processes for the preparation of the compounds.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55524695A | 1995-11-08 | 1995-11-08 | |
| US08/555,246 | 1995-11-08 | ||
| PCT/US1996/016585 WO1997017356A1 (en) | 1995-11-08 | 1996-10-17 | Tricyclic erythromycin derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2235942A1 true CA2235942A1 (en) | 1997-05-15 |
| CA2235942C CA2235942C (en) | 2005-12-06 |
Family
ID=29405982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2235942 Expired - Fee Related CA2235942C (en) | 1995-11-08 | 1996-10-17 | Tricyclic erythromycin derivatives |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2235942C (en) |
-
1996
- 1996-10-17 CA CA 2235942 patent/CA2235942C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2235942C (en) | 2005-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL123551A0 (en) | Tricyclic erythromycin derivatives | |
| CA2263972A1 (en) | 6-o-substituted ketolides having antibacterial activity | |
| RU93050124A (en) | NEW DERIVATIVES OF ERYTHROMYCIN, THE METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS | |
| IE832652L (en) | Derivatives of epimeric azahomoerythromycin. | |
| CA2253338A1 (en) | 6-o-substituted erythromycins and method for making them | |
| CA2145826A1 (en) | Lipopeptide derivatives, a process for their preparation and their use | |
| PT1021456E (en) | MACROCYCLIC DERIVATIVES OF ERITROMYCINES A AND B OF 13 MEMBER RINGS | |
| CA2307788A1 (en) | 2-halo-6-o-substituted ketolide derivatives | |
| CA2219656A1 (en) | Antibacterial cephalosporins | |
| CA2041417A1 (en) | Treatment of pancreatic disease with 15-keto-prostaglandin compounds | |
| CA2046069A1 (en) | Treatment of inflammatory diseases with 15-keto-prostaglandin compounds | |
| AU5290199A (en) | Erythromycin derivatives with antibiotic activity | |
| CA2078662A1 (en) | 4-desoxy-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof | |
| CA2179733A1 (en) | Anticonvulsant pseudofructopyranose sulfamates | |
| CA2137395A1 (en) | 9a-N-(N'-Carbamoyl) and 9a-N-(N' - Thiocarbamoyl) Derivatives of 9-Deoxo-9a-AZA-9a-Homoerythromycin A | |
| CA2253330A1 (en) | 6-o-substituted erythromycin compounds and method for making same | |
| CA2380455A1 (en) | 9a-azalides with antibacterial activity | |
| MY104109A (en) | Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives. | |
| IE873091L (en) | Optically active gyrase inhibitors, their preparation and¹use as antibiotics | |
| CA2103825A1 (en) | 17-hydroxyiminomethyl-5.beta., 14.beta.-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same | |
| WO2000010998A3 (en) | Pyridone antibiotic with improved safety profile | |
| CA2235942A1 (en) | Tricyclic erythromycin derivatives | |
| CA2041240A1 (en) | Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds | |
| CA2048245A1 (en) | Treatment of cataract with prostacyclin compounds | |
| ATE42305T1 (en) | ANTIBIOTICS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THEM. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |